Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Major innovation in fight against pleural cancer

05 Apr 2016 | Health Nutrition, A region on the move

Lille hospital plays a key role in new treatment for pleural cancer.

Healthcare innovation in Northern France

For over 10 years, medicine had made no progress in treating cancer of the pleura, the membrane lining the lungs.

But now the Bio-MAPS program, launched by Dr. Gérard Zalcman in close cooperation with 70 French hospital groups, has shown that Bevacizumab is effective in treating pleural cancer, significantly reducing mortality risk in 23% of patients who were treated with it.

Dr. Arnaud Scherpereel, head of pulmonology and thoracic oncology at Lille University Hospital Center (CHRU) and coordinator of the Bevacizumab project, stresses that the treatment is equally effective in all patient sub-groups, including those with the worst prognosis factors.

As a result, this new treatment solution is becoming the first-line therapy for patients with pleural cancer.

Back to news

News

Heineken brings €5.5 m in cutting-edge technology to Hauts-de-France

The brewer has invested more than €70 m in the Hauts-de-France Region in nearly a decade. Let’s take a look at its newest upgrade to the Pélican brewery, a strategic production site in Mons-en-Baroeul.

The EPMA opens an office in Hauts-de-France

The European Powder Metallurgy Association is setting up shop in Chantilly (Oise <Hauts-de-France). Interview with Executive Director Lionel Aboussouan on why the EPMA chose Chantilly and its future...

All news